Louis Chrystal 4
4 · TScan Therapeutics, Inc. · Filed May 3, 2024
Insider Transaction Report
Form 4
Louis Chrystal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-01+380,000→ 380,000 totalExercise: $8.62Exp: 2034-04-30→ Voting Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of April 22, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.